Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation ; volume:23 ; number:1 ; day:4 ; month:4 ; year:2023 ; pages:1-11 ; date:12.2023
BMC cardiovascular disorders ; 23, Heft 1 (4.4.2023), 1-11, 12.2023
- Urheber
-
Hwang, Ki Won
Choi, Jin Hee
Lee, Soo Yong
Lee, Sang Hyun
Chon, Min Ku
Lee, Jungkuk
Kim, Hasung
Kim, Yong-Giun
Choi, Hyung Oh
Kim, Jeong Su
Park, Yong-Hyun
Kim, June Hong
Chun, Kook Jin
Nam, Gi-Byoung
Choi, Kee-Joon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-023-03212-z
- URN
-
urn:nbn:de:101:1-2023081909162671356469
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hwang, Ki Won
- Choi, Jin Hee
- Lee, Soo Yong
- Lee, Sang Hyun
- Chon, Min Ku
- Lee, Jungkuk
- Kim, Hasung
- Kim, Yong-Giun
- Choi, Hyung Oh
- Kim, Jeong Su
- Park, Yong-Hyun
- Kim, June Hong
- Chun, Kook Jin
- Nam, Gi-Byoung
- Choi, Kee-Joon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
Indirect comparison of novel Oral anticoagulants among Asians with non-Valvular atrial fibrillation in the real world setting: a network meta-analysis
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
Indirect comparison of novel Oral anticoagulants among Asians with non-Valvular atrial fibrillation in the real world setting: a network meta-analysis
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population